222 related articles for article (PubMed ID: 24901292)
1. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols.
Davis JS; McMillan M; Swaminathan A; Kelly JA; Piera KE; Baird RW; Currie BJ; Anstey NM
Chest; 2014 Oct; 146(4):1038-1045. PubMed ID: 24901292
[TBL] [Abstract][Full Text] [Related]
2. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia.
Lan M; Dongmei K; Guodong S; Haifeng Y; Guofeng C; Mengting C; Xiaoyun F
BMC Infect Dis; 2024 Apr; 24(1):448. PubMed ID: 38671347
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
6. Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
Choi SH; Cho EB; Chung JW; Lee MK
J Infect Chemother; 2019 Jan; 25(1):6-11. PubMed ID: 30342838
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Severe Community-Acquired Pneumonia in Réunion Island due to Acinetobacter baumannii.
Rotini G; de Mangou A; Combe A; Jabot J; Puech B; Dangers L; Nativel M; Allou N; Miltgen G; Vidal C
Am J Trop Med Hyg; 2024 Jul; 111(1):136-140. PubMed ID: 38834085
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
[TBL] [Abstract][Full Text] [Related]
10. Attributable mortality of nosocomial Acinetobacter bacteremia.
Grupper M; Sprecher H; Mashiach T; Finkelstein R
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
12. Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia.
Kang FY; How CK; Wang YC; Cheng A; Yang YS; Kuo SC; Liu CP; Liu YM; Chen TL; Lee YT
Antimicrob Resist Infect Control; 2020 Sep; 9(1):160. PubMed ID: 32993810
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in Acinetobacter baumannii bacteremia.
Chen HP; Chen TL; Lai CH; Fung CP; Wong WW; Yu KW; Liu CY
J Microbiol Immunol Infect; 2005 Apr; 38(2):127-36. PubMed ID: 15843858
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
Guillamet CV; Vazquez R; Noe J; Micek ST; Kollef MH
Medicine (Baltimore); 2016 Aug; 95(35):e4708. PubMed ID: 27583907
[TBL] [Abstract][Full Text] [Related]
15. Blood stream infections caused by Acinetobacter baumannii group in Japan - Epidemiological and clinical investigation.
Fujikura Y; Yuki A; Hamamoto T; Kawana A; Ohkusu K; Matsumoto T
J Infect Chemother; 2016 Jun; 22(6):366-71. PubMed ID: 26993173
[TBL] [Abstract][Full Text] [Related]
16. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections.
Erbay A; Idil A; Gözel MG; Mumcuoğlu I; Balaban N
Int J Antimicrob Agents; 2009 Dec; 34(6):575-9. PubMed ID: 19740628
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
[TBL] [Abstract][Full Text] [Related]
18. Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality.
Hernández-Torres A; García-Vázquez E; Gómez J; Canteras M; Ruiz J; Yagüe G
Med Clin (Barc); 2012 May; 138(15):650-5. PubMed ID: 22093403
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia.
Lai HH; Liou BH; Chang YY; Kuo SC; Lee YT; Chen TL; Fung CP
J Microbiol Immunol Infect; 2016 Jun; 49(3):371-7. PubMed ID: 25081987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
